Currently holds positions in InterMune Inc, Obseva SA, Coherus BioSciences Inc and Natera Inc
Position | Company | Period |
---|---|---|
Independent Director | InterMune Inc | Jan. 1, 2000 - |
Independent Director | Obseva SA | Aug. 1, 2013 - |
Independent Director | Coherus BioSciences Inc | Feb. 1, 2014 - |
Independent Director | Natera Inc | Nov. 1, 2014 - |
Independent Director | Iterum Therapeutics PLC | Nov. 1, 2015 - Feb. 14, 2020 |
Independent Director | PDS Biotechnology Corp | April 1, 2015 - June 19, 2018 |
Non-Executive Independent Director | Amarin Corporation PLC | May 16, 2008 - Dec. 20, 2016 |
Independent Chairman of the Board | Humanigen Inc | Sept. 1, 2001 - June 18, 2014 |
Independent Director | Anthera Pharmaceuticals Inc | Aug. 1, 2006 - March 25, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-22 | 2023-12-13 |
Natera Inc
(NTRA)
|
S Sale |
644,000
-100.0%
58.7537,835,000 USD |
644,000 -100.0% | 58.75 | 37,835,000 USD | |
2023-01-17 | 2023-01-13 |
Karuna Therapeutics Inc
(KRTX)
|
S Sale |
6,027
-100.0%
199.901,204,771 USD |
6,027 -100.0% | 199.90 | 1,204,771 USD | |
2023-01-18 | 2022-11-16 |
Natera Inc
(NTRA)
|
S Sale |
2,400
-100.0%
37.7190,498 USD |
2,400 -100.0% | 37.71 | 90,498 USD | |
2022-08-15 | 2022-08-11 |
CinCor Pharma Inc
(CINC)
|
B Purchase |
6,000
+inf%
30.00180,000 USD |
6,000 +inf% | 30.00 | 180,000 USD | |
2022-08-15 | 2022-08-11 |
CinCor Pharma Inc
(CINC)
|
B Purchase |
500,000
+9.0%
30.0015,000,000 USD |
500,000 +9.0% | 30.00 | 15,000,000 USD | |
2022-04-14 | 2022-04-01 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
47
+7.4%
129.386,081 USD |
47 +7.4% | 129.38 | 6,081 USD | |
2022-01-13 | 2022-01-11 |
CinCor Pharma Inc
(CINC)
|
B Purchase |
325,000
+6.2%
16.005,200,000 USD |
325,000 +6.2% | 16.00 | 5,200,000 USD | |
2021-09-29 | 2021-09-29 |
Coherus BioSciences Inc
(CHRS)
|
S Sale |
286,076
-100.0%
16.124,611,545 USD |
286,076 -100.0% | 16.12 | 4,611,545 USD | |
2021-09-29 | 2021-09-28 |
Coherus BioSciences Inc
(CHRS)
|
S Sale |
48,329
-14.5%
17.17829,809 USD |
48,329 -14.5% | 17.17 | 829,809 USD | |
2021-09-29 | 2021-09-27 |
Coherus BioSciences Inc
(CHRS)
|
S Sale |
100,150
-23.0%
18.061,808,709 USD |
100,150 -23.0% | 18.06 | 1,808,709 USD | |
2021-02-09 | 2021-02-09 |
Bolt Biotherapeutics Inc
(BOLT)
|
B Purchase |
450,000
+19.5%
20.009,000,000 USD |
450,000 +19.5% | 20.00 | 9,000,000 USD | |
2020-09-11 | 2020-09-09 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
4,557
+0.2%
73.75336,079 USD |
4,557 +0.2% | 73.75 | 336,079 USD | |
2020-09-09 | 2020-09-08 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
504
+0.0%
73.0036,792 USD |
504 +0.0% | 73.00 | 36,792 USD | |
2020-09-09 | 2020-09-04 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
8,330
+0.4%
73.59613,005 USD |
8,330 +0.4% | 73.59 | 613,005 USD | |
2020-09-09 | 2020-09-04 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
6,461
+0.3%
72.73469,909 USD |
6,461 +0.3% | 72.73 | 469,909 USD | |
2020-09-09 | 2020-09-04 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
45,317
+2.4%
71.303,231,102 USD |
45,317 +2.4% | 71.30 | 3,231,102 USD | |
2020-09-09 | 2020-09-04 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
1,670
+0.1%
70.12117,100 USD |
1,670 +0.1% | 70.12 | 117,100 USD | |
2019-11-01 | 2019-10-30 |
Y-mAbs Therapeutics, Inc
(YMAB)
|
B Purchase |
90,000
+4.3%
28.002,520,000 USD |
90,000 +4.3% | 28.00 | 2,520,000 USD | |
2019-07-02 | 2019-07-02 |
Karuna Therapeutics Inc
(KRTX)
|
B Purchase |
700,000
+68.0%
16.0011,200,000 USD |
700,000 +68.0% | 16.00 | 11,200,000 USD | |
2019-07-02 | 2019-07-02 |
Coherus BioSciences Inc
(CHRS)
|
PS Planned sale |
160,000
-7.6%
22.613,617,600 USD |
160,000 -7.6% | 22.61 | 3,617,600 USD | |
2019-07-02 | 2019-06-28 |
Coherus BioSciences Inc
(CHRS)
|
PS Planned sale |
200,000
-8.7%
22.054,410,000 USD |
200,000 -8.7% | 22.05 | 4,410,000 USD | |
2019-06-24 | 2019-06-20 |
Coherus BioSciences Inc
(CHRS)
|
PS Planned sale |
317,130
-12.1%
21.376,777,068 USD |
317,130 -12.1% | 21.37 | 6,777,068 USD | |
2019-05-24 | 2019-05-22 |
Coherus BioSciences Inc
(CHRS)
|
PS Planned sale |
257,870
-9.0%
20.695,335,330 USD |
257,870 -9.0% | 20.69 | 5,335,330 USD | |
2018-09-25 | 2018-09-21 |
Y-mAbs Therapeutics, Inc
(YMAB)
|
B Purchase |
500,000
+31.2%
16.008,000,000 USD |
500,000 +31.2% | 16.00 | 8,000,000 USD | |
2004-10-19 | 2004-10-15 |
Cotherix Inc
(CTRX)
|
B Purchase |
5,243
+252.2%
6.0031,458 USD |
5,243 +252.2% | 6.00 | 31,458 USD | |
2004-10-19 | 2004-10-15 |
Cotherix Inc
(CTRX)
|
B Purchase |
341,933
+252.1%
6.002,051,598 USD |
341,933 +252.1% | 6.00 | 2,051,598 USD | |
2004-10-19 | 2004-10-15 |
Cotherix Inc
(CTRX)
|
B Purchase |
11,250
+252.1%
6.0067,500 USD |
11,250 +252.1% | 6.00 | 67,500 USD |